United Therapeutics (UTHR) Cash from Investing Activities (QoQ) (2009 - 2026)
United Therapeutics (UTHR) Cash from Investing Activities (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -88.23% |
| Mar 31, 2026 | 426.76% |
| Dec 31, 2025 | -261.53% |
| Sep 30, 2025 | 146.98% |
| Jun 30, 2025 | -82.09% |
| Mar 31, 2025 | -33.69% |
| Dec 31, 2024 | -7.22% |
| Sep 30, 2024 | -43.63% |
| Jun 30, 2024 | -110.88% |
| Mar 31, 2024 | 1,646.56% |
| Dec 31, 2023 | 113.43% |
| Sep 30, 2023 | -37.94% |
| Jun 30, 2023 | -2.76% |
| Mar 31, 2023 | -16.80% |
| Dec 31, 2022 | -101.38% |
| Sep 30, 2022 | 44.38% |
| Jun 30, 2022 | 52.95% |
| Mar 31, 2022 | -83.45% |
| Dec 31, 2021 | 17.00% |
| Sep 30, 2021 | -382.41% |